| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $511.4M | +9.7% |
| Cost of Revenue | $117.1M | +45.1% |
| Gross Profit | $394.4M | +2.3% |
| R&D Expense | $100.7M | +11.0% |
| SG&A Expense | $91.7M | +19.9% |
| Operating Income | $36.8M | -55.3% |
| Pre-tax Income | $2.4M | -95.6% |
| Income Tax | $19.4M | -16.7% |
| Net Income | -$17.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $111.8M | +31.3% |
| Accounts Receivable | $50.3M | +12.1% |
| Current Assets | $216.4M | +17.7% |
| Total Assets | $1.41B | +5.3% |
| Current Liabilities | $181.8M | +21.1% |
| Long-term Debt | $393.9M | +18.2% |
| Total Liabilities | $605.3M | +4.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $93.2M | +17.3% |
| Capital Expenditures | $18.1M | +3.2% |
| Investing Cash Flow | -$29.0M | +76.3% |
| Financing Cash Flow | -$40.6M | -79.8% |
| Free Cash Flow | $75.1M | +21.3% |
| -155.0% |
| EPS (Basic) | -$0.09 | -152.9% |
| EPS (Diluted) | -$0.09 | -156.3% |
| Stockholders' Equity |
| $804.7M |
| +6.0% |